1 / 29

Prenatal diagnosis (PND) in Joubert syndrome

Prenatal diagnosis (PND) in Joubert syndrome. Dan Doherty, MD/PhD. Goals of PND. Provide reassurance/reduce uncertainty Prepare for the birth of an affected child Delivery route Delivery location Emotional preparation Assure the birth of an unaffected child Pregnancy termination

lee-quinn
Download Presentation

Prenatal diagnosis (PND) in Joubert syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Prenatal diagnosis (PND) in Joubert syndrome Dan Doherty, MD/PhD

  2. Goals of PND • Provide reassurance/reduce uncertainty • Prepare for the birth of an affected child • Delivery route • Delivery location • Emotional preparation • Assure the birth of an unaffected child • Pregnancy termination • (Preimplantation genetic diagnosis) • Allow for prenatal treatment

  3. JS is autosomal recessive* Recurrence risk = 25%

  4. Reproductive options • Accept the risk without PND

  5. Reproductive options • Accept the risk without PND • Accept the risk and consider PND: • To prepare for an affected child • To terminate an affected pregnancy

  6. Reproductive options • Accept the risk without PND • Accept the risk and consider PND: • To prepare for an affected child • To terminate an affected pregnancy • Sperm or egg donor to reduce risk

  7. Reproductive options • Accept the risk without PND • Accept the risk and consider PND: • To prepare for an affected child • To terminate an affected pregnancy • Sperm or egg donor to reduce risk • Choose to adopt

  8. Reproductive options • Accept the risk without PND • Accept the risk and consider PND: • To prepare for an affected child • To terminate an affected pregnancy • Sperm or egg donor to reduce risk • Choose to adopt • Choose not to have additional children

  9. Reproductive options • Accept the risk without PND • Accept the risk and consider PND: • To prepare for an affected child • To terminate an affected pregnancy • Sperm or egg donor to reduce risk • Choose to adopt • Choose not to have additional children ALL of these choices are valid.

  10. Risk scenarios • Prior affected child: 25% risk each pregnancy • Clinical diagnosis only -> prenatal imaging • Clinical and genetic diagnosis -> genetic testing and prenatal imaging • No family history: population risk (very low) • Routine prenatal care • Population risk of birth defects 2-3%

  11. Testing Strategies • Available • Prenatal imaging • Fetal DNA testing • Not Available • Maternal serum screening • Biochemical testing (amniotic fluid)

  12. Imaging diagnosis • Consistent finding • Cerebellar vermis hypoplasia • Molar tooth sign not seen before 24 weeks • Supportive findings (rare) • Polydactyly • Cystic kidneys • Encephalocele • Increased respiratory rate

  13. Vermis hypoplasia US Superior vermis intact Inferior vermis absent

  14. Vermis hypoplasia fetal MRI 21 wks Affected 22 wks Unaffected

  15. Molar tooth sign in utero 29 wks gestation Post-natal

  16. Polydactyly in utero 2 3 1 4 5 6 Aslan et al. 2002

  17. Encephalocele in utero US (not JS) Fetal MRI (JS)

  18. Specific imaging strategy • Usual prenatal care and screening • Consultation with a tertiary care center • 16-18 week US • 20 week US • 20-22 week fetal MRI adapted from Doherty et al. 2005 We are happy to consult with OB providers/radiologists about imaging diagnosis. We prefer to be involved starting before/early in the pregnancy.

  19. Imaging diagnosis • Advantages: • Non-invasive • Can visualize brain, fingers, kidneys • Can be repeated throughout pregnancy • Relatively inexpensive • Disadvantages: • Technician-dependent • Radiologist-dependent • May not see subtle abnormalities • Late diagnosis

  20. Background: Genetic Testing Gene Estimated frequency NPHP1 ~2% AHI1 ~10% CEP290 ~10% RPGRIP1L ~5% MKS3 ~10% ARL13B <1% CC2D2A ~10% INPP5E ? OFD1 <1% TOTAL <50% Frequency of mutations in patients with JS

  21. DNA testing strategy • Test affected child prior to next pregnancy

  22. DNA testing strategy • Test affected child prior to next pregnancy • Test affected child prior to next pregnancy

  23. DNA testing strategy • Test affected child prior to next pregnancy • Test affected child prior to next pregnancy • No mutation identified -> PND by imaging

  24. DNA testing strategy • Test affected child prior to pregnancy • Test affected child prior to pregnancy • No mutation identified -> PND by imaging • Mutation identified • Preimplantation genetic diagnosis • Chorionic villous sampling • Amniocentesis

  25. DNA collection techniques • early placental tissue • 10-12wk gestation • Risks: • Miscarriage (1/100) • Infection • Less available in US • DNA dx 12-14 wks Chorionic villus sampling

  26. DNA collection techniques Amniocentesis • fetal skin cells in fluid • >15 wk gestation • Risks: • Miscarriage (1/500) • Infection • Fluid leak • Fetal injury • DNA dx ~20+ wks

  27. Making a Decision • Genetic Counselor or Geneticist can help • Discuss options • Provide resources and support • Consider contacting them before pregnancy or early in pregnancy • See www.nsgc.org for a list of local GC’s

  28. Conclusions • Family history of JS • Known mutation -> PND by gene testing • No mutation -> PND by prenatal US & fetal MRI • No family history • JS not distinguishable from other cerebellar vermis hypoplasias before 24wks • Variable features can facilitate diagnosis • Encephalocele, polydactyly, cystic kidneys • After 27wks, dx possible by imaging alone

  29. Acknowledgements University of Washington Joubert Center http://depts.washington.edu/joubert/ Dana Knutzen, Genetic Counselor 206-616-3788 knutzd@u.washington.edu

More Related